Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes
Public ClinicalTrials.gov record NCT01456195. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 mg and 50 mg Compared With Placebo in Subjects With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the efficacy and safety of TAK-875 (fasiglifam), once daily (QD), in participants with type 2 diabetes mellitus (T2DM).
Study identification
- NCT ID
- NCT01456195
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 421 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2011 (Type not available)
- Primary completion
- Jul 2013 (Actual)
- Completion
- Jul 2013 (Actual)
- Last update posted
- Apr 5, 2016
2011 – 2013
United States locations
- U.S. sites
- 55
- U.S. states
- 24
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Dothan | Alabama | — | — |
| Not listed | Muscle Shoals | Alabama | — | — |
| Not listed | Goodyear | Arizona | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | North Hollywood | California | — | — |
| Not listed | Norwalk | California | — | — |
| Not listed | Palm Springs | California | — | — |
| Not listed | Pismo Beach | California | — | — |
| Not listed | Boynton Beach | Florida | — | — |
| Not listed | Bradenton | Florida | — | — |
| Not listed | Coral Gables | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Largo | Florida | — | — |
| Not listed | New Port Richey | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Decatur | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Avon | Indiana | — | — |
| Not listed | Greenfield | Indiana | — | — |
| Not listed | Muncie | Indiana | — | — |
| Not listed | Council Bluffs | Iowa | — | — |
| Not listed | Topeka | Kansas | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Oxon Hill | Maryland | — | — |
| Not listed | Flint | Michigan | — | — |
| Not listed | Picayune | Mississippi | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Elizabeth | New Jersey | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Greensboro | North Carolina | — | — |
| Not listed | Mooresville | North Carolina | — | — |
| Not listed | Morganton | North Carolina | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Maumee | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Harleysville | Pennsylvania | — | — |
| Not listed | Levittown | Pennsylvania | — | — |
| Not listed | Uniontown | Pennsylvania | — | — |
| Not listed | Greer | South Carolina | — | — |
| Not listed | Crossville | Tennessee | — | — |
| Not listed | Carrollton | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | El Pasco | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Irving | Texas | — | — |
| Not listed | New Braunfels | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Spring | Texas | — | — |
| Not listed | Tomball | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Burke | Virginia | — | — |
| Not listed | Manassas | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01456195, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2016 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01456195 live on ClinicalTrials.gov.